Pleural fluid tests to diagnose tuberculous pleuritis

Area of Science:

• Pulmonology
• Infectious Diseases
• Diagnostic Accuracy

Background:

• Tuberculous pleuritis (TBP) diagnosis relies on Mycobacterium tuberculosis isolation, which has low sensitivity.
• Pleural fluid tests are explored to improve TBP diagnosis due to culture limitations and biopsy invasiveness.
• Adenosine deaminase (ADA) is a widely used pleural fluid marker, but its accuracy varies with TBP prevalence.

Purpose of the Study:

• To summarize current data on the diagnostic accuracy of pleural fluid tests for tuberculous pleuritis (TBP).
• To evaluate the utility of various biomarkers in different TBP prevalence settings.
• To assess the role of interferon-gamma and interleukin-27 in conjunction with ADA.

Main Methods:

• Review of existing data on pleural fluid tests for TBP diagnosis.
• Analysis of the accuracy of adenosine deaminase (ADA) alone and in combination with other markers.
• Evaluation of test performance across varying TBP prevalence rates.

Main Results:

• No single pleural fluid test reliably rules in TBP in low-prevalence settings.
• Interferon-gamma (IFN-γ), alone or with ADA, is more reliable for ruling in TBP in non-low prevalence settings.
• ADA reliably rules out TBP at <40% prevalence; the product of interleukin-27 and ADA is best for ruling out TBP at higher prevalences.

Conclusions:

• Pleural fluid test accuracy for TBP is highly dependent on local disease prevalence.
• Combining ADA with IFN-γ or interleukin-27 enhances diagnostic capabilities for TBP.
• Optimized use of pleural fluid biomarkers can improve TBP diagnosis, complementing traditional methods.